LIVE EVENT Q&A: Dr. Andrew Huberman Question & Answer in Toronto, ON

Huberman’s series with psychiatrist Dr. Paul Conti aims to provide accessible practices for understanding and improving mental health without requiring formal therapy. Techniques like dream and liminal-state reflection and ‘mirror work’ help people access the unconscious in a structured way, while forthcoming relationship content emphasizes balancing aggressive, pleasure, and generative drives rather than focusing on labels like ‘narcissist’ or superficial compatibility.

Huberman argues that we overemphasize in-the-moment hacks and under-appreciate daily practices that raise our threshold for stress. Good sleep, regular stress-exposure training (getting comfortable with adrenaline), and robust morning routines set nervous system tone so we are less likely to ‘snap.’ In real time, tools are limited—physiological sighs can help—but the bulk of the work is long-term nervous system care, not crisis-only interventions.

Citing Joe Strummer’s ‘no input, no output,’ Huberman suggests that great ideas arise when diverse experiences are allowed to ‘geyser up’ from the unconscious. He deliberately walks or runs without headphones, avoiding language-based inputs to enter ‘wordless’ states. In these moments, previously collected sensory experiences recombine internally, leading to delight and inspiration—distinct from passive awe, which doesn’t connect to personal action.

Seasonal depression is tied to how the melatonin signal lengthens across days as light shortens, not just absolute day length. The brain ‘remembers’ yesterday’s melatonin duration. By progressively increasing bright-light exposure in the morning through fall into winter (via sunlight when possible or bright artificial sources such as ~900-lux tablets or bright bulbs), you can trick the system into perceiving less of a slide into prolonged darkness, thereby easing seasonal mood shifts.

Whether change is driven by focused learning, talk therapy, breathing practices, or psychedelics, the common pathway involves neuromodulators like serotonin, dopamine, acetylcholine, and epinephrine. Macro-dose psychedelic therapies (MDMA, psilocybin) appear promising for conditions like depression and PTSD by massively increasing serotonin and broadening brain connectivity, but they are not risk-free and should not be a first-line or casual approach—especially for children, for whom enriched learning (e.g., music) better mimics healthy plasticity patterns.